Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie’s disease
2018 ◽
Vol 31
(1)
◽
pp. 15-19
◽
2018 ◽
Vol 31
(1)
◽
pp. 54-55
◽
Keyword(s):
2019 ◽
Vol 32
(2)
◽
pp. 257-258
2019 ◽
Vol 32
(2)
◽
pp. 251-252
◽
2005 ◽
Vol 173
(4S)
◽
pp. 255-255
◽
2005 ◽
Vol 173
(4S)
◽
pp. 253-253
◽